MCM2 and adenocarcinoma: In addition, mRNA analysis of a PDX model of NEPC transdifferentiation revealed increased expression of CDC7,MCM2, MCM3, and MCM4 as the AR-positive adenocarcinoma model (LTL331) transitioned to the NEPC phenotype (LTL331R) (Fig. 1C)29.